Mediwelcome Healthcare Management & Technology Inc. provided consolidated earnings guidance for the year ended 31 December 2022. For the year, the Group is expected to record an unaudited consolidated net loss attributable to owners of the Company of not less than RMB 80.0 million for the Year, as compared to an audited consolidated profit attributable to owners of the Company of approximately RMB 4.6 million for the year ended 31 December 2021.
Mediwelcome Healthcare Management & Technology Inc.
Equities
2159
KYG5960A1076
Business Support Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 HKD | 0.00% | -18.60% | -31.37% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.37% | 10.24M | |
+9.32% | 14.45B | |
-7.19% | 1.13B | |
-6.41% | 716M | |
-14.48% | 554M | |
-12.33% | 532M | |
-34.09% | 516M | |
+22.73% | 295M | |
0.00% | 263M | |
+114.94% | 216M |
- Stock Market
- Equities
- 2159 Stock
- News Mediwelcome Healthcare Management & Technology Inc.
- Mediwelcome Healthcare Management & Technology Inc. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022